ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.45
-0.83%
US Tech 100
19,088.00
0.10%
S&P 500
5,412.52
-0.39%
US Dollar vs CAD
1.37753
0.23%
Bitcoin
66,839.88
0.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) News

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DateTimeSourceHeadlineSymbolCompany
06/13/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/13/20244:00PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/12/20244:01PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/12/20248:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/11/20244:17PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/11/20243:49PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/10/20247:53AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/202410:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/202410:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock SplitNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/05/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/30/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/30/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/29/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/28/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International ConventionNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/24/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/24/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/24/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/24/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/22/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/22/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/22/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/21/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/21/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/15/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/13/20243:56PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/13/20243:56PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Your Recent History

USOTC
GTVH
Golden Triangle Ventures (PK)
AMEX
BURU
Nuburu
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
NLST
Netlist (QB)
USOTC
KEGS
1812 Brewing (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
RDGL
Vivos (QB)
USOTC
IQST
iQSTEL (QX)
NASDAQ
FFIE
Faraday Future Intellige...
NASDAQ
TSLA
Tesla
USOTC
PHIL
PHI (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
CNNA
Cann American (CE)
USOTC
ENZC
Enzolytics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved